However, the research team cautions that evidence is still limited and showing varied results
When compared with placebo or other therapies, GLP-1 agonists were associated with an increased risk of biliary disease [23]: Overall biliary disease: RR 1.37(95% CI 1.231.52) Cholelithiasis: RR 1.27 (95% CI 1.101.47) Cholecystitis: RR 1.36 (95% CI 1.141.62) Mechanisms: Reduced gallbladder motility Rapid weight loss increased cholesterol saturation and gallstone formation
[1] Nausea is one of the most commonly reported adverse effects, classified as 'very common' in the UK product information, affecting approximately 44% of patients in clinical trials, with frequency varying by dose
This new class of drugs are an example of medical science at its best a way for people to achieve dramatic results and, in doing so, have a chance at a much higher quality of life, says Lifeforce Co-Founder Dugal Bain-Kim
As retatrutide works in a similar way, its likely that you should avoid alcohol in these cases too
Just consistent, all-day Replying to @Clo yo hope this helps!! #kindpatchesglp1 #kindpatches Kind Patches You guys need to try this omg it works